世界の後腹膜線維症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Retroperitoneal Fibrosis Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5993
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、107ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、後腹膜線維症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（コルチコステロイド、免疫抑制剤）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・後腹膜線維症治療の市場動向
・企業の競争状況、市場シェア
・後腹膜線維症治療の種類別市場規模と予測2016-2027（コルチコステロイド、免疫抑制剤）
・後腹膜線維症治療の用途別市場規模と予測2016-2027（病院薬局、小売薬局、オンライン薬局、その他）
・後腹膜線維症治療の北米市場規模2016-2027（アメリカ、カナダ）
・後腹膜線維症治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・後腹膜線維症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・後腹膜線維症治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・後腹膜線維症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（AstraZeneca、Eli Lilly and Company、GlaxoSmithKline、Abbott Laborites、Johnson and Johnson、Sanofi、Pfizer、Merck & Company、Bayer、Novartis）
・結論

Retroperitoneal fibrosis is the rare disease also known as Ormond’s disease. Retroperitoneal fibrosis is characterized by the inflammatory disorder in which abnormal formation of tissue or fibrosis occurs in the back of the abdominal cavity and behind the retro membrane. This area is known as retroperitoneal space. The abnormal tissue growth affects the urinary tubes of the kidney. Often these tubes are blocked by fibrosis.

Market Analysis and Insights: Global Retroperitoneal Fibrosis Treatment Market
The global Retroperitoneal Fibrosis Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Retroperitoneal Fibrosis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Retroperitoneal Fibrosis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Retroperitoneal Fibrosis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Retroperitoneal Fibrosis Treatment market.

Global Retroperitoneal Fibrosis Treatment Scope and Market Size
Retroperitoneal Fibrosis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Retroperitoneal Fibrosis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Corticosteroids
Immunosuppressant

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AstraZeneca
Eli Lilly and Company
GlaxoSmithKline
Abbott Laborites
Johnson and Johnson
Sanofi
Pfizer
Merck & Company
Bayer
Novartis

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Retroperitoneal Fibrosis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Corticosteroids
1.2.3 Immunosuppressant
1.3 Market by Application
1.3.1 Global Retroperitoneal Fibrosis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Retroperitoneal Fibrosis Treatment Market Perspective (2016-2027)
2.2 Retroperitoneal Fibrosis Treatment Growth Trends by Regions
2.2.1 Retroperitoneal Fibrosis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Retroperitoneal Fibrosis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Retroperitoneal Fibrosis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Retroperitoneal Fibrosis Treatment Industry Dynamic
2.3.1 Retroperitoneal Fibrosis Treatment Market Trends
2.3.2 Retroperitoneal Fibrosis Treatment Market Drivers
2.3.3 Retroperitoneal Fibrosis Treatment Market Challenges
2.3.4 Retroperitoneal Fibrosis Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Retroperitoneal Fibrosis Treatment Players by Revenue
3.1.1 Global Top Retroperitoneal Fibrosis Treatment Players by Revenue (2016-2021)
3.1.2 Global Retroperitoneal Fibrosis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Retroperitoneal Fibrosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Retroperitoneal Fibrosis Treatment Revenue
3.4 Global Retroperitoneal Fibrosis Treatment Market Concentration Ratio
3.4.1 Global Retroperitoneal Fibrosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Retroperitoneal Fibrosis Treatment Revenue in 2020
3.5 Retroperitoneal Fibrosis Treatment Key Players Head office and Area Served
3.6 Key Players Retroperitoneal Fibrosis Treatment Product Solution and Service
3.7 Date of Enter into Retroperitoneal Fibrosis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Retroperitoneal Fibrosis Treatment Breakdown Data by Type
4.1 Global Retroperitoneal Fibrosis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Retroperitoneal Fibrosis Treatment Forecasted Market Size by Type (2022-2027)

5 Retroperitoneal Fibrosis Treatment Breakdown Data by Application
5.1 Global Retroperitoneal Fibrosis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Retroperitoneal Fibrosis Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Retroperitoneal Fibrosis Treatment Market Size (2016-2027)
6.2 North America Retroperitoneal Fibrosis Treatment Market Size by Type
6.2.1 North America Retroperitoneal Fibrosis Treatment Market Size by Type (2016-2021)
6.2.2 North America Retroperitoneal Fibrosis Treatment Market Size by Type (2022-2027)
6.2.3 North America Retroperitoneal Fibrosis Treatment Market Size by Type (2016-2027)
6.3 North America Retroperitoneal Fibrosis Treatment Market Size by Application
6.3.1 North America Retroperitoneal Fibrosis Treatment Market Size by Application (2016-2021)
6.3.2 North America Retroperitoneal Fibrosis Treatment Market Size by Application (2022-2027)
6.3.3 North America Retroperitoneal Fibrosis Treatment Market Size by Application (2016-2027)
6.4 North America Retroperitoneal Fibrosis Treatment Market Size by Country
6.4.1 North America Retroperitoneal Fibrosis Treatment Market Size by Country (2016-2021)
6.4.2 North America Retroperitoneal Fibrosis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Retroperitoneal Fibrosis Treatment Market Size (2016-2027)
7.2 Europe Retroperitoneal Fibrosis Treatment Market Size by Type
7.2.1 Europe Retroperitoneal Fibrosis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Retroperitoneal Fibrosis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Retroperitoneal Fibrosis Treatment Market Size by Type (2016-2027)
7.3 Europe Retroperitoneal Fibrosis Treatment Market Size by Application
7.3.1 Europe Retroperitoneal Fibrosis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Retroperitoneal Fibrosis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Retroperitoneal Fibrosis Treatment Market Size by Application (2016-2027)
7.4 Europe Retroperitoneal Fibrosis Treatment Market Size by Country
7.4.1 Europe Retroperitoneal Fibrosis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Retroperitoneal Fibrosis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Retroperitoneal Fibrosis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Retroperitoneal Fibrosis Treatment Market Size by Type
8.2.1 Asia-Pacific Retroperitoneal Fibrosis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Retroperitoneal Fibrosis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Retroperitoneal Fibrosis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Retroperitoneal Fibrosis Treatment Market Size by Application
8.3.1 Asia-Pacific Retroperitoneal Fibrosis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Retroperitoneal Fibrosis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Retroperitoneal Fibrosis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Retroperitoneal Fibrosis Treatment Market Size by Region
8.4.1 Asia-Pacific Retroperitoneal Fibrosis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Retroperitoneal Fibrosis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Retroperitoneal Fibrosis Treatment Market Size (2016-2027)
9.2 Latin America Retroperitoneal Fibrosis Treatment Market Size by Type
9.2.1 Latin America Retroperitoneal Fibrosis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Retroperitoneal Fibrosis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Retroperitoneal Fibrosis Treatment Market Size by Type (2016-2027)
9.3 Latin America Retroperitoneal Fibrosis Treatment Market Size by Application
9.3.1 Latin America Retroperitoneal Fibrosis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Retroperitoneal Fibrosis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Retroperitoneal Fibrosis Treatment Market Size by Application (2016-2027)
9.4 Latin America Retroperitoneal Fibrosis Treatment Market Size by Country
9.4.1 Latin America Retroperitoneal Fibrosis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Retroperitoneal Fibrosis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Retroperitoneal Fibrosis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Retroperitoneal Fibrosis Treatment Market Size by Type
10.2.1 Middle East & Africa Retroperitoneal Fibrosis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Retroperitoneal Fibrosis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Retroperitoneal Fibrosis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Retroperitoneal Fibrosis Treatment Market Size by Application
10.3.1 Middle East & Africa Retroperitoneal Fibrosis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Retroperitoneal Fibrosis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Retroperitoneal Fibrosis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Retroperitoneal Fibrosis Treatment Market Size by Country
10.4.1 Middle East & Africa Retroperitoneal Fibrosis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Retroperitoneal Fibrosis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Retroperitoneal Fibrosis Treatment Introduction
11.1.4 AstraZeneca Revenue in Retroperitoneal Fibrosis Treatment Business (2016-2021)
11.1.5 AstraZeneca Recent Development
11.2 Eli Lilly and Company
11.2.1 Eli Lilly and Company Company Details
11.2.2 Eli Lilly and Company Business Overview
11.2.3 Eli Lilly and Company Retroperitoneal Fibrosis Treatment Introduction
11.2.4 Eli Lilly and Company Revenue in Retroperitoneal Fibrosis Treatment Business (2016-2021)
11.2.5 Eli Lilly and Company Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Retroperitoneal Fibrosis Treatment Introduction
11.3.4 GlaxoSmithKline Revenue in Retroperitoneal Fibrosis Treatment Business (2016-2021)
11.3.5 GlaxoSmithKline Recent Development
11.4 Abbott Laborites
11.4.1 Abbott Laborites Company Details
11.4.2 Abbott Laborites Business Overview
11.4.3 Abbott Laborites Retroperitoneal Fibrosis Treatment Introduction
11.4.4 Abbott Laborites Revenue in Retroperitoneal Fibrosis Treatment Business (2016-2021)
11.4.5 Abbott Laborites Recent Development
11.5 Johnson and Johnson
11.5.1 Johnson and Johnson Company Details
11.5.2 Johnson and Johnson Business Overview
11.5.3 Johnson and Johnson Retroperitoneal Fibrosis Treatment Introduction
11.5.4 Johnson and Johnson Revenue in Retroperitoneal Fibrosis Treatment Business (2016-2021)
11.5.5 Johnson and Johnson Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Retroperitoneal Fibrosis Treatment Introduction
11.6.4 Sanofi Revenue in Retroperitoneal Fibrosis Treatment Business (2016-2021)
11.6.5 Sanofi Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Retroperitoneal Fibrosis Treatment Introduction
11.7.4 Pfizer Revenue in Retroperitoneal Fibrosis Treatment Business (2016-2021)
11.7.5 Pfizer Recent Development
11.8 Merck & Company
11.8.1 Merck & Company Company Details
11.8.2 Merck & Company Business Overview
11.8.3 Merck & Company Retroperitoneal Fibrosis Treatment Introduction
11.8.4 Merck & Company Revenue in Retroperitoneal Fibrosis Treatment Business (2016-2021)
11.8.5 Merck & Company Recent Development
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Bayer Business Overview
11.9.3 Bayer Retroperitoneal Fibrosis Treatment Introduction
11.9.4 Bayer Revenue in Retroperitoneal Fibrosis Treatment Business (2016-2021)
11.9.5 Bayer Recent Development
11.10 Novartis
11.10.1 Novartis Company Details
11.10.2 Novartis Business Overview
11.10.3 Novartis Retroperitoneal Fibrosis Treatment Introduction
11.10.4 Novartis Revenue in Retroperitoneal Fibrosis Treatment Business (2016-2021)
11.10.5 Novartis Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Retroperitoneal Fibrosis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Corticosteroids
Table 3. Key Players of Immunosuppressant
Table 4. Global Retroperitoneal Fibrosis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Retroperitoneal Fibrosis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Retroperitoneal Fibrosis Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Retroperitoneal Fibrosis Treatment Market Share by Regions (2016-2021)
Table 8. Global Retroperitoneal Fibrosis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Retroperitoneal Fibrosis Treatment Market Share by Regions (2022-2027)
Table 10. Retroperitoneal Fibrosis Treatment Market Trends
Table 11. Retroperitoneal Fibrosis Treatment Market Drivers
Table 12. Retroperitoneal Fibrosis Treatment Market Challenges
Table 13. Retroperitoneal Fibrosis Treatment Market Restraints
Table 14. Global Retroperitoneal Fibrosis Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Retroperitoneal Fibrosis Treatment Market Share by Players (2016-2021)
Table 16. Global Top Retroperitoneal Fibrosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retroperitoneal Fibrosis Treatment as of 2020)
Table 17. Ranking of Global Top Retroperitoneal Fibrosis Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Retroperitoneal Fibrosis Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Retroperitoneal Fibrosis Treatment Product Solution and Service
Table 21. Date of Enter into Retroperitoneal Fibrosis Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Retroperitoneal Fibrosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Retroperitoneal Fibrosis Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Retroperitoneal Fibrosis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Retroperitoneal Fibrosis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Retroperitoneal Fibrosis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Retroperitoneal Fibrosis Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Retroperitoneal Fibrosis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Retroperitoneal Fibrosis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Retroperitoneal Fibrosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Retroperitoneal Fibrosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Retroperitoneal Fibrosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Retroperitoneal Fibrosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Retroperitoneal Fibrosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Retroperitoneal Fibrosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Retroperitoneal Fibrosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Retroperitoneal Fibrosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Retroperitoneal Fibrosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Retroperitoneal Fibrosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Retroperitoneal Fibrosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Retroperitoneal Fibrosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Retroperitoneal Fibrosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Retroperitoneal Fibrosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Retroperitoneal Fibrosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Retroperitoneal Fibrosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Retroperitoneal Fibrosis Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Retroperitoneal Fibrosis Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Retroperitoneal Fibrosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Retroperitoneal Fibrosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Retroperitoneal Fibrosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Retroperitoneal Fibrosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Retroperitoneal Fibrosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Retroperitoneal Fibrosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Retroperitoneal Fibrosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Retroperitoneal Fibrosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Retroperitoneal Fibrosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Retroperitoneal Fibrosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Retroperitoneal Fibrosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Retroperitoneal Fibrosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. AstraZeneca Company Details
Table 62. AstraZeneca Business Overview
Table 63. AstraZeneca Retroperitoneal Fibrosis Treatment Product
Table 64. AstraZeneca Revenue in Retroperitoneal Fibrosis Treatment Business (2016-2021) & (US$ Million)
Table 65. AstraZeneca Recent Development
Table 66. Eli Lilly and Company Company Details
Table 67. Eli Lilly and Company Business Overview
Table 68. Eli Lilly and Company Retroperitoneal Fibrosis Treatment Product
Table 69. Eli Lilly and Company Revenue in Retroperitoneal Fibrosis Treatment Business (2016-2021) & (US$ Million)
Table 70. Eli Lilly and Company Recent Development
Table 71. GlaxoSmithKline Company Details
Table 72. GlaxoSmithKline Business Overview
Table 73. GlaxoSmithKline Retroperitoneal Fibrosis Treatment Product
Table 74. GlaxoSmithKline Revenue in Retroperitoneal Fibrosis Treatment Business (2016-2021) & (US$ Million)
Table 75. GlaxoSmithKline Recent Development
Table 76. Abbott Laborites Company Details
Table 77. Abbott Laborites Business Overview
Table 78. Abbott Laborites Retroperitoneal Fibrosis Treatment Product
Table 79. Abbott Laborites Revenue in Retroperitoneal Fibrosis Treatment Business (2016-2021) & (US$ Million)
Table 80. Abbott Laborites Recent Development
Table 81. Johnson and Johnson Company Details
Table 82. Johnson and Johnson Business Overview
Table 83. Johnson and Johnson Retroperitoneal Fibrosis Treatment Product
Table 84. Johnson and Johnson Revenue in Retroperitoneal Fibrosis Treatment Business (2016-2021) & (US$ Million)
Table 85. Johnson and Johnson Recent Development
Table 86. Sanofi Company Details
Table 87. Sanofi Business Overview
Table 88. Sanofi Retroperitoneal Fibrosis Treatment Product
Table 89. Sanofi Revenue in Retroperitoneal Fibrosis Treatment Business (2016-2021) & (US$ Million)
Table 90. Sanofi Recent Development
Table 91. Pfizer Company Details
Table 92. Pfizer Business Overview
Table 93. Pfizer Retroperitoneal Fibrosis Treatment Product
Table 94. Pfizer Revenue in Retroperitoneal Fibrosis Treatment Business (2016-2021) & (US$ Million)
Table 95. Pfizer Recent Development
Table 96. Merck & Company Company Details
Table 97. Merck & Company Business Overview
Table 98. Merck & Company Revenue in Retroperitoneal Fibrosis Treatment Business (2016-2021) & (US$ Million)
Table 99. Merck & Company Recent Development
Table 100. Bayer Company Details
Table 101. Bayer Business Overview
Table 102. Bayer Retroperitoneal Fibrosis Treatment Product
Table 103. Bayer Revenue in Retroperitoneal Fibrosis Treatment Business (2016-2021) & (US$ Million)
Table 104. Bayer Recent Development
Table 105. Novartis Company Details
Table 106. Novartis Business Overview
Table 107. Novartis Retroperitoneal Fibrosis Treatment Product
Table 108. Novartis Revenue in Retroperitoneal Fibrosis Treatment Business (2016-2021) & (US$ Million)
Table 109. Novartis Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Retroperitoneal Fibrosis Treatment Market Share by Type: 2020 VS 2027
Figure 2. Corticosteroids Features
Figure 3. Immunosuppressant Features
Figure 4. Global Retroperitoneal Fibrosis Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Retail Pharmacies Case Studies
Figure 7. Online Pharmacies Case Studies
Figure 8. Others Case Studies
Figure 9. Retroperitoneal Fibrosis Treatment Report Years Considered
Figure 10. Global Retroperitoneal Fibrosis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Retroperitoneal Fibrosis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Retroperitoneal Fibrosis Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Retroperitoneal Fibrosis Treatment Market Share by Regions (2022-2027)
Figure 14. Global Retroperitoneal Fibrosis Treatment Market Share by Players in 2020
Figure 15. Global Top Retroperitoneal Fibrosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retroperitoneal Fibrosis Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Retroperitoneal Fibrosis Treatment Revenue in 2020
Figure 17. Global Retroperitoneal Fibrosis Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Retroperitoneal Fibrosis Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Retroperitoneal Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Retroperitoneal Fibrosis Treatment Market Share by Type (2016-2027)
Figure 21. North America Retroperitoneal Fibrosis Treatment Market Share by Application (2016-2027)
Figure 22. North America Retroperitoneal Fibrosis Treatment Market Share by Country (2016-2027)
Figure 23. United States Retroperitoneal Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Retroperitoneal Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Retroperitoneal Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Retroperitoneal Fibrosis Treatment Market Share by Type (2016-2027)
Figure 27. Europe Retroperitoneal Fibrosis Treatment Market Share by Application (2016-2027)
Figure 28. Europe Retroperitoneal Fibrosis Treatment Market Share by Country (2016-2027)
Figure 29. Germany Retroperitoneal Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Retroperitoneal Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Retroperitoneal Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Retroperitoneal Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Retroperitoneal Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Retroperitoneal Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Retroperitoneal Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Retroperitoneal Fibrosis Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Retroperitoneal Fibrosis Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Retroperitoneal Fibrosis Treatment Market Share by Region (2016-2027)
Figure 39. China Retroperitoneal Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Retroperitoneal Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Retroperitoneal Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Retroperitoneal Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Retroperitoneal Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Retroperitoneal Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Retroperitoneal Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Retroperitoneal Fibrosis Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Retroperitoneal Fibrosis Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Retroperitoneal Fibrosis Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Retroperitoneal Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Retroperitoneal Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Retroperitoneal Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Retroperitoneal Fibrosis Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Retroperitoneal Fibrosis Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Retroperitoneal Fibrosis Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Retroperitoneal Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Retroperitoneal Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Retroperitoneal Fibrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. AstraZeneca Revenue Growth Rate in Retroperitoneal Fibrosis Treatment Business (2016-2021)
Figure 59. Eli Lilly and Company Revenue Growth Rate in Retroperitoneal Fibrosis Treatment Business (2016-2021)
Figure 60. GlaxoSmithKline Revenue Growth Rate in Retroperitoneal Fibrosis Treatment Business (2016-2021)
Figure 61. Abbott Laborites Revenue Growth Rate in Retroperitoneal Fibrosis Treatment Business (2016-2021)
Figure 62. Johnson and Johnson Revenue Growth Rate in Retroperitoneal Fibrosis Treatment Business (2016-2021)
Figure 63. Sanofi Revenue Growth Rate in Retroperitoneal Fibrosis Treatment Business (2016-2021)
Figure 64. Pfizer Revenue Growth Rate in Retroperitoneal Fibrosis Treatment Business (2016-2021)
Figure 65. Merck & Company Revenue Growth Rate in Retroperitoneal Fibrosis Treatment Business (2016-2021)
Figure 66. Bayer Revenue Growth Rate in Retroperitoneal Fibrosis Treatment Business (2016-2021)
Figure 67. Novartis Revenue Growth Rate in Retroperitoneal Fibrosis Treatment Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

以下、関連資料のご紹介

世界の皮膚線維症治療市場規模・現状・予測（2021年-2027年）

Global Treatment of Skin Fibrosis Market Size, Status and Forecast 2021-2027
QFJ1-6052 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、皮膚線維症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（コルチコステロイド、抗線維化剤、免疫療法薬、その他）、用途別市場規模（病院薬局、小売薬局、その他）、主要地域別市場規模（北米、アメリカ、欧...

世界の特発性肺線維症治療市場規模・現状・予測（2021年-2027年）

Global Idiopathic Pulmonary Fibrosis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4345 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、特発性肺線維症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（医薬品クラス、酸素療法、肺移植、その他）、用途別市場規模（病院、診療所）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国...

世界の腎臓/腎線維化治療市場規模・現状・予測（2021年-2027年）

Global Kidney/Renal Fibrosis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4404 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、腎臓/腎線維化治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アンジオテンシンII受容体拮抗薬（ARB）、アンジオテンシン変換酵素（ACE）阻害薬、ピルフェニドン、レニン阻害薬、バソペプチダーゼ阻...

世界の嚢胞性線維症治療市場規模・現状・予測（2021年-2027年）

Global Cystic Fibrosis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4091 2021年6月 127Pages
QYResearch社発行の本調査レポートでは、嚢胞性線維症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南ア...

世界の非嚢胞性線維症気管支拡張症市場規模・現状・予測（2021年-2027年）

Global Non-Cystic Fibrosis Bronchiectasis Market Size, Status and Forecast 2021-2027
QFJ1-4587 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、非嚢胞性線維症気管支拡張症の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、静脈注射）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界の心筋線維症市場規模・現状・予測（2021年-2027年）

Global Myocardial Fibrosis Market Size, Status and Forecast 2021-2027
QFJ1-4542 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、心筋線維症の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（小分子治療法、タンパク質治療法、ペプチド治療法、エンドグリン抗体療法法、幹細胞治療法、RNA治療法、その他）、用途別市場規模（病院、クリニック...

世界の皮膚線維症治療薬市場規模・現状・予測（2021年-2027年）

Global Cutaneous Fibrosis Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4077 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、皮膚線維症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（コルチコステロイド、抗線維化薬、免疫グロブリン）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリ...

世界の嚢胞性線維症診断検査市場規模・現状・予測（2021年-2027年）

Global Cystic Fibrosis Diagnostic Tests Market Size, Status and Forecast 2021-2027
QFJ1-4090 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、嚢胞性線維症診断検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（遺伝子検査、糞便検査、免疫反応性トリプシノーゲン（IRT）検査、塩化汗検査、呼吸機能検査）、用途別市場規模（病院、診断研究所、その他...

世界の未分化甲状腺がん治療市場規模・現状・予測（2021年-2027年）

Global Anaplastic Thyroid Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3803 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、未分化甲状腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界のOAB治療市場規模・現状・予測（2021年-2027年）

Global OAB Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5902 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、OAB治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗コリン作用薬、ミラベグロン、ボトックス）、用途別市場規模（特発性過活動膀胱、神経性過活動膀胱）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の皮膚線維症治療市場規模・現状・予測（2021年-2027年） It refers to the treatment of skin myelofibrosis by drugs such as corticosteroids, anti-fibrotic drugs, and immunotherapy drugs. Market Analysis and Insights: Global Treatment of Skin Fibrosis Market The global Treatment of Skin Fibrosis market size is projected to reach US$ XX million by 2027, from…
世界の皮膚線維症治療薬市場規模・現状・予測（2021年-2027年） Dermal fibrosis is a fundamental feature of fatty skin sclerosis and is associated with increased levels of the cytokine transforming growth factor-β,186. This growth factor maybe derived from activated leukocytes, recruits macrophages and fibroblasts into the tissue and leads to the production of e…
世界の特発性肺線維症治療市場規模・現状・予測（2021年-2027年） Idiopathic Pulmonary Fibrosis Treatment is treatment work on a lung disease which causes the tissue in your lungs to become stiff. Market Analysis and Insights: Global Idiopathic Pulmonary Fibrosis Treatment Market The global Idiopathic Pulmonary Fibrosis Treatment market size is projected to reach…
世界の腎臓/腎線維化治療市場規模・現状・予測（2021年-2027年） Kidney/Renal fibrosis, defined as an aberrant wound healing process in response to chronic injury, is characterized by the progressive and persistent accumulation of extracellular matrix components (ECM) in the kidney, ultimately leading to renal failure. Market Analysis and Insights: Global Kidney/…
世界の嚢胞性線維症治療市場規模・現状・予測（2021年-2027年） Cystic fibrosis (CF) is a hereditary disease characterized by abnormalities in the body's salt, aquatic cells, and mucus-producing cells. Market Analysis and Insights: Global Cystic Fibrosis Treatment Market The global Cystic Fibrosis Treatment market size is projected to reach US$ XX million by 202…